Glucoamylase provides a way to adjust the sweetness of an oat drink by releasing glucose from oat-derived starch fragments. The useful endpoint is the desired balance of sugars, body and flavour, rather than complete conversion to glucose.
What glucoamylase does
Glucoamylase acts from non-reducing carbohydrate chain ends, hydrolysing alpha-1,4 linkages and, more slowly, some alpha-1,6 branch linkages. Alpha-amylase first improves access by shortening starch chains and reducing viscosity. Glucoamylase then increases glucose formation; it is not a replacement for a well-controlled cooking and liquefaction stage.
Choosing between beta-amylase and glucoamylase
Beta-amylase is the maltose-producing option after liquefaction; glucoamylase is the glucose-producing option. They are not equivalent substitutions. Where retaining maltose is the priority, begin without glucoamylase, because it can hydrolyse maltose further to glucose. Compare the two routes at matched oat solids and final processing conditions, using measured maltose and glucose concentrations alongside sensory assessment.
Product selection and operating conditions
Scientific & Technical's Glucoamylase listing gives an activity of 300,000 U/g, a temperature range of 15–60°C and a pH range of 3.5–8.0. These are listed operating ranges, not a claim of equal performance throughout them. Confirm the current lot activity, assay conditions and recommended process settings before scale-up.
For a first bench screen, use a liquefied oat base at 50–55°C and measure its natural pH. Establish performance at that pH before deciding whether acidification is necessary. This is a proposed development screen, not a validated oat-milk optimum. Do not copy a glucose-syrup pH recipe into a finished beverage without checking flavour and protein stability.
Step-by-step trial
- Prepare one homogeneous batch of liquefied oat base with alpha-amylase. Keep oat solids and the liquefaction endpoint constant between comparisons.
- Split into matched vessels and cool to the selected glucoamylase temperature. Keep one vessel without glucoamylase; it shows the background sugar level and any continuing alpha-amylase effect.
- Use a supplier-supported starting dose for this preparation, comparing 0.5×, 1× and 2× that dose. Express addition per kg dry oats or per kg starch, stating which basis is used.
- Take samples at 0, 15, 30 and 60 minutes. Immediately stop enzyme activity in analytical samples with a validated method so their sugar concentrations do not continue changing.
- Measure glucose with a suitable specific assay or chromatography. Measure viscosity and taste only samples prepared under the appropriate food-safe trial procedure.
- Select the lowest dose and shortest hold that deliver the agreed glucose and sensory targets after final processing. Confirm that the stopping step prevents further sugar formation.
Dose and scale-up calculations
For an activity-based dose, product mass (g) = target activity (U/g substrate) × substrate mass (g) ÷ product activity (U/g product). The substrate can be starch or dry oats, but it must match the basis of the tested dose. Do not use an oat-based dose as a starch-based dose without conversion.
For illustration only, 100 U/g dry oats applied to 100 kg dry oats using a preparation rated 300,000 U/g gives 33.3 g product. This is a calculation example, not a recommended oat-milk dosage. If dosing a liquid by volume, use the confirmed density and the lot's activity basis; U/g is not automatically U/mL.
How to control sweetness
- Set a measured glucose or total-sugar specification before choosing the reaction time. A sweetness target should be assessed alongside mouthfeel and flavour.
- Use refractometer readings as a rapid process trend, not as a glucose assay. Soluble dextrins and other dissolved components contribute to the reading.
- An iodine test can indicate remaining starch structure but cannot establish a final glucose concentration.
- Do not assume maximum hydrolysis gives the best beverage. Compare partially converted samples and an alpha-amylase-only control.
- Confirm final sugar composition analytically before making nutrition or sweetness claims.
Troubleshooting
- Too sweet: reduce glucoamylase dose or hold time and check residual activity after the stopping step.
- Conversion appears slow: check actual temperature, pH, activity loss and the preceding liquefaction step before adding more enzyme.
- Body falls during the hold: reduce conversion and reassess the complete formulation rather than correcting only the sugar concentration.
- Protein instability after pH adjustment: reassess whether the acidic stage is necessary and evaluate the sequence relative to protein glutaminase.
How the four enzymes fit together
Alpha-amylase shortens starch chains to control viscosity. Beta-amylase releases maltose from accessible chain ends. Glucoamylase releases glucose and can further hydrolyse maltose. Protein glutaminase modifies protein-bound glutamine to improve protein functionality. Select the sugar-producing enzymes according to the desired maltose/glucose profile; all four are not mandatory in every recipe.
A development sequence is: disperse oats in water; cook and liquefy starch with a suitable alpha-amylase; cool and adjust pH for beta-amylase when a maltose-rich profile is wanted; use glucoamylase only where additional glucose formation is intended; establish compatible conditions for protein glutaminase; stop enzyme activity using a validated process; separate coarse solids as required; formulate, homogenise and apply the validated final preservation process. Compare protein treatment before and after separation if protein recovery matters.
For a maltose-led formulation, start with alpha-amylase plus beta-amylase and compare it with alpha-amylase alone. For a glucose-led formulation, evaluate alpha-amylase plus glucoamylase. If both saccharifying enzymes are used, measure both sugars: adding glucoamylase can shift the balance away from maltose. Protein glutaminase addresses protein functionality in either route.
Do not assume one temperature and pH suit all four enzymes. The listed beta-amylase pH range ends at 6.0, whereas the protein-glutaminase optimum is 6.0–7.0. Establish sequential stages first and adjust pH where needed. A nominal overlap does not prove efficient simultaneous operation.
Finishing and quality checks
Enzyme treatment is one part of beverage manufacture. Filtration or centrifugation, oil addition, mineral salts, homogenisation and the final heat treatment can all change the result. Test the finished formulation, including any calcium fortification, rather than judging the enzyme-treated slurry alone.
Measure viscosity at a defined temperature and shear condition, solids, glucose or sugar profile, protein recovery, sedimentation and sensory properties. For a barista product, also test steaming, foam drainage and stability in the intended coffee. Record the actual heating and cooling profile, not only the vessel set point.
Confirm residual enzyme activity after the stopping step. Enzyme inactivation and microbiological preservation are separate validation requirements; the trial holding conditions in this guide are not a pasteurisation, UHT or shelf-life specification. Avoid enzyme dust and aerosols and follow each product's safety data sheet.
Evidence and scope
Research comparing amylase addition sequences in oat milk found that enzyme choice and sequence affected physical stability. A study using alpha-amylase, glucoamylase and pullulanase does not establish an optimum for an alpha-amylase/glucoamylase/protein-glutaminase process; the protein enzyme has a different role.
Liang et al. (2024): effects of enzymatic hydrolysis modes on oat-milk stability
View Glucoamylase
Beta-Amylase for Oat Milk: Maltose Production and Sweetness Control
Alpha-Amylase for Oat Milk: Liquefaction and Viscosity Control
Protein Glutaminase for Oat Milk: Protein Solubility and Functionality
Process development and supply
Contact Scientific & Technical with your oat loading, batch size, enzyme grades, temperature and pH profile, target sweetness and protein specification. These details allow a trial dose and scale-up plan to be matched to your process.
Discuss your oat-milk application
